(IN BRIEF) Boehringer Ingelheim has licensed a pre-clinical small molecule program from Kyowa Kirin to develop a potential first-in-class therapy for autoimmune diseases, a major global health challenge affecting around 10% of the population. The deal grants Boehringer exclusive worldwide … Read the full press release
Posted in Business, Financial, Germany, Healthcare, Industrial, Investment, Management, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged autoimmune diseases, biotechnology, Boehringer Ingelheim, Boehringer Ingelheim Secures Exclusive Global Rights to Develop New Autoimmune Treatment from Kyowa Kirin, Boehringer Ingelheim Strengthens Autoimmune Disease Pipeline with Licensing Agreement from Kyowa Kirin, Carine Boustany, chronic inflammation, drug development, global health, immunology, inflammatory diseases, Kyowa Kirin, licensing agreement, pharmaceutical innovation, pre-clinical program, respiratory diseases, small molecule therapy, Takeyoshi Yamashita
(IN BRIEF) A collaborative study led by Bayer and Hurdle, in partnership with top academic institutions including the University of Birmingham and the University of Edinburgh, has introduced and validated InflammAge—a novel, non-invasive saliva-based biomarker that quantifies systemic chronic inflammation, … Read the full press release
Posted in Business, Education, European Union, Financial, Industrial, Investment, Management, News, Pharma & Biotech, Science, Switzerland, Technology, United Kingdom
Tagged aging, Bayer, Cancer, cardiovascular disease, chronic inflammation, CRP, Dr. Daniel Martin-Herranz, Generation Scotland, Hurdle, InflammAge, lifestyle factors, neurodegenerative disorders, non-invasive testing, partnership, precision medicine, Professor Janet M Lord, Professor Riccardo E. Marioni, remote health monitoring, saliva-based DNA methylation biomarker, University of Birmingham, University of Edinburgh, Veronika Óvári
MUNICH, 09-Jan-2018 — /EuropaWire/ — Multiple Sclerosis (MS) is a chronic inflammatory disease of the central nervous system, in which the body’s own immune cells attack the fatty, insulating myelin sheath surrounding nerve fibers. The regeneration of intact myelin … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?